跳至主要内容
临床试验/JPRN-jRCTs061180064
JPRN-jRCTs061180064已完成未知

Clinical study of D-psicose for diabetic neuropathy - DPDN study

hitomi imachi0 个研究点目标入组 9 人开始时间: 2019年3月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
9

研究概览

简要总结

In this study, which evaluated the difference in mean nerve conduction velocity from the start of administration to 12 weeks after administration, the results showed that additional administration of D-psicose did not exacerbate diabetic neuropathy. This was a test of the hypothesis that diabetic neuropathy is not exacerbated, but as a subject of this study, we believe that more detailed analysis was possible once the target number of target cases was reached.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • type 2 diabetes patient over 20 years old who have diabetic neuropathy and can not obtain sufficient effect by any of the following treatments (HbA1c 6.5% or more and less than 8.0%)
  • 1) Diet therapy or exercise therapy only
  • 2) Pharmacotherapy in addition to diet therapy / exercise therapy

排除标准

  • 1) Patients falling under D-psicose administration contraindications
  • 2) Patients participating in other trials
  • 3) A pregnant woman, a maternity woman, a lactating woman or a woman having a possibility of pregnancy
  • 4) Patients who have poor glycemic control with HbA1c> 8%
  • 5) Patients who have severe renal dysfunction (serum creatinine value> 1.5 mg / dl)
  • 6) Patients with other serious complications
  • 7) Patients judged inappropriate as subjects by other doctor's judgment
  • 8) Patients undergoing drug therapy for diabetic neuropathy

研究者

发起方
hitomi imachi

相似试验